Prospera Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
27,704
+14,424
+109% +$783K 0.02% 695
2026
Q1
$833K Buy
13,280
+4,486
+51% +$359K 0.01% 794
2025
Q4
$838K Sell
8,794
-136
-2% -$13.3K 0.01% 747
2025
Q3
$872K Sell
8,930
-321
-3% -$33.2K 0.01% 730
2025
Q2
$994K Buy
9,251
+1,348
+17% +$136K 0.02% 657
2025
Q1
$797K Buy
7,903
+1,092
+16% +$110K 0.02% 626
2024
Q4
$608K Buy
6,811
+30
+0.4% +$2.64K 0.01% 680
2024
Q3
$568K Sell
6,781
-329
-5% -$25.9K 0.01% 681
2024
Q2
$548K Buy
7,110
+299
+4% +$21.9K 0.02% 681
2024
Q1
$466K Buy
6,811
+436
+7% +$28K 0.01% 729
2023
Q4
$369K Sell
6,375
-781
-11% -$41.7K 0.01% 762
2023
Q3
$378K Buy
7,156
+463
+7% +$24.3K 0.01% 713
2023
Q2
$362K Sell
6,693
-131
-2% -$6.84K 0.01% 715
2023
Q1
$341K Buy
6,824
+245
+4% +$11.5K 0.01% 743
2022
Q4
$304K Sell
6,579
-261
-4% -$11.3K 0.02% 699
2022
Q3
$266K Buy
6,840
+5,244
+329% +$210K 0.01% 687
2022
Q2
$59K Sell
1,596
-4,876
-75% -$198K ﹤0.01% 1002
2022
Q1
$287K Buy
6,472
+691
+12% +$29.9K 0.01% 756
2021
Q4
$246K Sell
5,781
-3,493
-38% -$147K 0.01% 767
2021
Q3
$402K Buy
9,274
+500
+6% +$22.1K 0.02% 587
2021
Q2
$375K Buy
8,774
+1
+0% +$42 0.02% 599
2021
Q1
$339K Sell
8,773
-47
-0.5% -$1.78K 0.02% 587
2020
Q4
$317K Buy
8,820
+4,738
+116% +$171K 0.02% 525
2020
Q3
$156K Sell
4,082
-4,389
-52% -$169K 0.06% 291
2020
Q2
$297K Buy
+8,471
New +$305K 0.03% 447

Other funds holding BSX

Prospera Financial Services's BSX Position: Q2 2026 in Review

Prospera Financial Services increased its Boston Scientific (BSX) stake by 109% in Q2 2026, buying an estimated $783K and bringing the position to 27,704 shares worth $1.18M. The position accounts for 0.02% of the portfolio, ranked #695.

Prospera Financial Services first reported a position in BSX in Q2 2020 and has held it in 25 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Prospera Financial Services held 27,704 shares of Boston Scientific worth $1.18M as of Q2 2026.
  • Prospera Financial Services bought 14,424 Boston Scientific shares in Q2 2026, an estimated $783K.
  • Boston Scientific made up 0.02% of Prospera Financial Services's portfolio in Q2 2026, its #695 holding.
  • Prospera Financial Services first reported a position in Boston Scientific in Q2 2020 and has held it in 25 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.